• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏膜侵犯而非切除不完全,对乳房外佩吉特病患者的长期生存有负面影响。

Mucosal Invasion, but Not Incomplete Excision, Has Negative Impact on Long-Term Survival in Patients With Extramammary Paget's Disease.

作者信息

Hashimoto Hiroki, Kaku-Ito Yumiko, Furue Masutaka, Ito Takamichi

机构信息

Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

Front Oncol. 2021 Apr 15;11:642919. doi: 10.3389/fonc.2021.642919. eCollection 2021.

DOI:10.3389/fonc.2021.642919
PMID:33937045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8082157/
Abstract

BACKGROUND

Extramammary Paget's disease (EMPD) sometimes spreads from the skin to mucosal areas, and curative surgical excision of these areas is challenging. The aim of this study is to analyze the impact of mucosal involvement and surgical treatment on the survival of patients with EMPD.

METHODS

We conducted a retrospective review of 217 patients with EMPD. We also assessed the associations between tumor involvement in boundary areas (anal canal, external urethral meatus, vaginal introitus), prognostic factors, and survival in 198 patients treated with curative surgery.

RESULTS

Of 217 patients, 75 (34.6%) had mucosal boundary area involvement. Lesions in these areas were associated with frequent lymphovascular invasion ( = 0.042), lymph node metastasis ( = 0.0002), incomplete excision ( < 0.0001), and locoregional recurrence ( < 0.0001). Boundary area involvement was an independent prognostic factor associated with disease-specific survival, per multivariate analysis (HR: 11.87, = 0.027). Incomplete excision was not significantly correlated with disease-specific survival (HR: 1.05, = 0.96).

CONCLUSION

Boundary area tumor involvement was a major risk factor for incomplete excision, local recurrence, and poor survival outcomes. However, incomplete removal of primary tumors was not significantly associated with poor prognosis. A less invasive surgical approach for preserving anogenital and urinary functions may be acceptable as the first-line treatment for resectable EMPD.

摘要

背景

乳腺外佩吉特病(EMPD)有时会从皮肤扩散至黏膜区域,对这些区域进行根治性手术切除具有挑战性。本研究的目的是分析黏膜受累及手术治疗对EMPD患者生存的影响。

方法

我们对217例EMPD患者进行了回顾性研究。我们还评估了198例接受根治性手术治疗患者的肿瘤在边界区域(肛管、尿道外口、阴道口)的累及情况、预后因素与生存之间的关联。

结果

在217例患者中,75例(34.6%)有黏膜边界区域受累。这些区域的病变与频繁的淋巴管侵犯(P = 0.042)、淋巴结转移(P = 0.0002)、切除不完全(P < 0.0001)及局部区域复发(P < 0.0001)相关。根据多因素分析,边界区域受累是与疾病特异性生存相关的独立预后因素(HR:11.87,P = 0.027)。切除不完全与疾病特异性生存无显著相关性(HR:1.05,P = 0.96)。

结论

边界区域肿瘤累及是切除不完全、局部复发及生存不良结局的主要危险因素。然而,原发肿瘤切除不完全与预后不良无显著关联。一种保留肛门生殖和泌尿功能的侵入性较小的手术方法作为可切除EMPD的一线治疗可能是可以接受的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/8082157/fed41bfc0b62/fonc-11-642919-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/8082157/03cf2b4de5cf/fonc-11-642919-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/8082157/fed41bfc0b62/fonc-11-642919-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/8082157/03cf2b4de5cf/fonc-11-642919-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/8082157/fed41bfc0b62/fonc-11-642919-g002.jpg

相似文献

1
Mucosal Invasion, but Not Incomplete Excision, Has Negative Impact on Long-Term Survival in Patients With Extramammary Paget's Disease.黏膜侵犯而非切除不完全,对乳房外佩吉特病患者的长期生存有负面影响。
Front Oncol. 2021 Apr 15;11:642919. doi: 10.3389/fonc.2021.642919. eCollection 2021.
2
Five- and 10-year survival in extramammary Paget's disease: A focus on wide local excision.乳房外派杰特病的 5 年和 10 年生存率:关注广泛局部切除。
Asia Pac J Clin Oncol. 2024 Oct;20(5):604-610. doi: 10.1111/ajco.13964. Epub 2023 May 3.
3
The role of sentinel lymph node biopsy in the management of invasive extramammary Paget's disease: Multi-center, retrospective study of 151 patients.前哨淋巴结活检在侵袭性乳腺外佩吉特病管理中的作用:151例患者的多中心回顾性研究
J Dermatol Sci. 2015 Jul;79(1):38-42. doi: 10.1016/j.jdermsci.2015.03.014. Epub 2015 Apr 18.
4
Functional preservation benefits of minimal surgery for extramammary Paget's disease.保功能手术治疗乳房外 Paget 病的优势。
Exp Dermatol. 2023 Oct;32(10):1644-1650. doi: 10.1111/exd.14866. Epub 2023 Jun 28.
5
Current Management and Treatment of Extramammary Paget's Disease.目前对派杰氏病的治疗和管理。
Curr Treat Options Oncol. 2022 Jun;23(6):818-830. doi: 10.1007/s11864-021-00923-3. Epub 2022 Apr 4.
6
Survival analysis of extramammary Paget's disease (EMPD) in a tertiary hospital in Taiwan.台湾某三级医院乳腺外佩吉特病(EMPD)的生存分析。
World J Surg Oncol. 2021 Apr 12;19(1):110. doi: 10.1186/s12957-021-02228-z.
7
Outcomes of lymph node dissection in the treatment of extramammary Paget's disease: A single-institution study.淋巴结清扫术治疗乳腺外派杰病的疗效:单中心研究。
J Dermatol. 2020 May;47(5):512-517. doi: 10.1111/1346-8138.15285. Epub 2020 Mar 10.
8
Primary invasive carcinoma associated with penoscrotal extramammary Paget's disease: a clinicopathological analysis of 56 cases.原发性侵袭性癌与阴茎阴囊部外 Paget 病相关:56 例临床病理分析。
BJU Int. 2015 Jan;115(1):153-60. doi: 10.1111/bju.12776. Epub 2014 Oct 17.
9
Extramammary Paget's disease: treatment, prognostic factors and outcome in 76 patients.乳房外佩吉特病:76例患者的治疗、预后因素及结局
Br J Dermatol. 2008 Feb;158(2):313-8. doi: 10.1111/j.1365-2133.2007.08314.x. Epub 2007 Nov 19.
10
CDK4: A Novel Therapeutic Target for Extramammary Paget's Disease.细胞周期蛋白依赖性激酶4:一种治疗乳房外佩吉特病的新靶点。
Front Oncol. 2021 Jul 29;11:710378. doi: 10.3389/fonc.2021.710378. eCollection 2021.

引用本文的文献

1
A multicenter study on TROP2 as a potential targeted therapy for extramammary Paget disease in Japan.一项关于TROP2作为日本乳腺外佩吉特病潜在靶向治疗的多中心研究。
Sci Rep. 2025 Jan 2;15(1):409. doi: 10.1038/s41598-024-84566-y.
2
Independent Risk Factors for Postoperative Recurrence of Patients with Primary Extramammary Paget's Disease: A Retrospective Analysis.原发性乳房外佩吉特病患者术后复发的独立危险因素:一项回顾性分析。
Clin Cosmet Investig Dermatol. 2024 Jul 1;17:1557-1564. doi: 10.2147/CCID.S468103. eCollection 2024.
3
FOXM1: a new therapeutic target of extramammary Paget disease.

本文引用的文献

1
Clinical Characteristics, Treatment, and Prognostic Factors of Patients With Primary Extramammary Paget's Disease (EMPD): A Retrospective Analysis of 44 Patients From a Single Center and an Analysis of Data From the Surveillance, Epidemiology, and End Results (SEER) Database.原发性乳房外佩吉特病(EMPD)患者的临床特征、治疗及预后因素:来自单一中心的44例患者回顾性分析及监测、流行病学和最终结果(SEER)数据库数据分析
Front Oncol. 2020 Aug 25;10:1114. doi: 10.3389/fonc.2020.01114. eCollection 2020.
2
NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic Target.NECTIN4 在乳腺外帕哲病中的表达:一个新的治疗靶点的启示。
Int J Mol Sci. 2020 Aug 16;21(16):5891. doi: 10.3390/ijms21165891.
3
叉头框蛋白M1:一种乳腺外佩吉特病的新治疗靶点。
Sci Rep. 2024 Feb 19;14(1):4048. doi: 10.1038/s41598-024-54773-8.
4
KS-EMPD-1: a novel cell line of primary extramammary Paget's disease.KS-EMPD-1:一种原发性外阴 Paget 病的新型细胞系。
Hum Cell. 2023 Sep;36(5):1813-1829. doi: 10.1007/s13577-023-00951-1. Epub 2023 Jul 11.
5
Current Management and Treatment of Extramammary Paget's Disease.目前对派杰氏病的治疗和管理。
Curr Treat Options Oncol. 2022 Jun;23(6):818-830. doi: 10.1007/s11864-021-00923-3. Epub 2022 Apr 4.
6
Nectin-4: a Novel Therapeutic Target for Skin Cancers.黏附素-4:皮肤癌的新治疗靶点。
Curr Treat Options Oncol. 2022 Apr;23(4):578-593. doi: 10.1007/s11864-022-00940-w. Epub 2022 Mar 21.
7
CDK4: A Novel Therapeutic Target for Extramammary Paget's Disease.细胞周期蛋白依赖性激酶4:一种治疗乳房外佩吉特病的新靶点。
Front Oncol. 2021 Jul 29;11:710378. doi: 10.3389/fonc.2021.710378. eCollection 2021.
8
Trop2 Expression in Extramammary Paget's Disease and Normal Skin.Trop2 在乳腺外 Paget 病和正常皮肤中的表达。
Int J Mol Sci. 2021 Jul 19;22(14):7706. doi: 10.3390/ijms22147706.
Extramammary Paget disease of the vulva: Management and prognosis.
外阴派杰病:处理与预后。
Gynecol Oncol. 2020 Apr;157(1):146-150. doi: 10.1016/j.ygyno.2019.11.009. Epub 2019 Nov 25.
4
Extramammary Paget's Disease: A Review of the Literature Part II: Treatment and Prognosis.乳房外 Paget 病:文献回顾 第二部分:治疗和预后。
Dermatol Surg. 2020 Mar;46(3):305-311. doi: 10.1097/DSS.0000000000002240.
5
First-time versus recurrent penoscrotal extramammary Paget's disease: Clinicopathological characteristics and risk factors in 164 Chinese male patients.首次与复发的阴囊外乳房外派杰氏病:164 例中国男性患者的临床病理特征和危险因素。
Indian J Dermatol Venereol Leprol. 2020 Mar-Apr;86(2):134-140. doi: 10.4103/ijdvl.IJDVL_382_18.
6
Extramammary Paget Disease: A Review of the Literature-Part I: History, Epidemiology, Pathogenesis, Presentation, Histopathology, and Diagnostic Work-up.乳房外帕哲病:文献回顾——第一部分:历史、流行病学、发病机制、临床表现、组织病理学和诊断方法。
Dermatol Surg. 2020 Feb;46(2):151-158. doi: 10.1097/DSS.0000000000002064.
7
Approaches to High-Risk Resected Stage II and III Melanoma.高危切除的II期和III期黑色素瘤的治疗方法。
Am Soc Clin Oncol Educ Book. 2019 Jan;39:e207-e211. doi: 10.1200/EDBK_239283. Epub 2019 May 17.
8
Extramammary Paget's disease: a review of the literature.乳房外 Paget 病:文献复习。
Int J Dermatol. 2019 Aug;58(8):871-879. doi: 10.1111/ijd.14328. Epub 2018 Dec 19.
9
Vulvar Paget disease: A national retrospective cohort study.外阴派杰病:一项全国性回顾性队列研究。
J Am Acad Dermatol. 2019 Oct;81(4):956-962. doi: 10.1016/j.jaad.2018.11.016. Epub 2018 Nov 17.
10
Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.黑色素瘤分期:美国癌症联合委员会(AJCC)第8版及以后版本
Ann Surg Oncol. 2018 Aug;25(8):2105-2110. doi: 10.1245/s10434-018-6513-7. Epub 2018 May 30.